Singleplex Immunoassay Market Outlook portrays the Industry Benefits from Technological Advancements

Komentar · 466 Tampilan

Singular Precision: Explore the singleplex immunoassay market and uncover how it's redefining precision in diagnostics

Singleplex Immunoassay Market Highlights

The singleplex immunoassay market insights report expects the industry to gain prominence over the forecast period (2022–2030). It is estimated that the global singleplex immunoassay market is expected to register USD 260 Million at a CAGR ~9.30% during 2022–2030.

Immunoassays are highly adaptable which are designed to detect the binding of the specific antibody to the target analyte. Singleplex immunoassays are generally used to analyze multiple intracellular and extracellular proteins and gene expression quantification.

The global singleplex immunoassay market is driven by various factors such as growth in pharmaceutical and biotechnology sector, growing prevalence of chronic diseases, and raising awareness about immunoassay. Moreover, increased focus on diagnostic testing and growing government assistance are fueling the growth of the global singleplex immunoassay market. Additionally, many prominent players are engaged in the development of singleplex immunoassays products to maintain their market position. For instance, BioVendor develops, and markets Q-Plex Human iL-7 kit for singleplex immunoassays.

On the other hand, stringent FDA regulations and emergence of other immunoassay technologies many hamper the growth of the market during the forecast period.

Regional Analysis

The global singleplex immunoassay market consists of four regions: Americas, Europe, Asia Pacific and the Middle East Africa. Americas is expected to account for the largest market share owing to the presence of a large number of market players, increasing the prevalence of cancer, immunological diseases, and metabolic diseases. The American Cancer Society estimated that approximately 1,688,780 new cancer cases were diagnosed in America. Europe is anticipated to hold the second position in the market owing to the increasing prevalence of chronic diseases, funding's provided by the government, and private organizations towards research development. Asia Pacific is the fastest growing region in the global singleplex immunoassay market owing to the growing patient pool, high incidence of chronic diseases, developing healthcare infrastructure and increasing research development activities in the biotechnology sector, and rising healthcare expenditure. The Middle East and Africa are anticipated to grow steadily due to the presence of stringent government policies and poor economies, especially in the Africa region.

Segmentation

The global singleplex immunoassay market is segmented on the basis of the product and service, type, technology, application, and end user. On the basis of the product and services, the market is classified as consumables, instruments, and others. The global singleplex immunoassay market on the basis of the type is segmented as protein-based assays, nucleic acid-based assays, cell-based assays and others. On the basis of technology, the market is segmented into flow cytometry, fluorescence detection, and others. The global singleplex immunoassay market, by application, is segmented into research and development, clinical diagnostics, and others. The research and development are further segmented into drug discovery development and biomarker discovery and validation. The clinical diagnostics are further segmented into infectious diseases, cancer, cardiovascular diseases, autoimmune diseases, nervous system disorders, and metabolism endocrinology disorders. On the basis of the end user, the global singleplex immunoassay market is segmented as pharmaceutical biotechnology companies, hospitals research institutes, reference laboratories and others.

Global Singleplex Immunoassay Market Key Players

Luminex, Thermo Fisher Scientific, Illumina, Bio-Rad Laboratories, QIAGEN N.V, Abcam, Becton Dickinson and Company, Merck Life sciences, Agilent Technologies, BioVendor, Quanterix, Bio-Techne, Olink, Seegene are some prominent key players highlighted in the singleplex immunoassay market outlook report.

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact Us:

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor

New York, NY 10013

United States of America

+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: [email protected]

Website: https://www.marketresearchfuture.com

Komentar